Clinical trials
Terminated Phase 2 Nervous System Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2013 | 2 |
| 2017 | 3 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Flex Pharma, Inc. | 2 |
| Affiris AG | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| GlaxoSmithKline | 1 |
| Inmune Bio, Inc. | 1 |
| Neurologix, Inc. | 1 |
| Novartis Pharmaceuticals | 1 |
| Oregon Health and Science University | 1 |
| VA Office of Research and Development | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nervous System Diseases | 10 |
| Neurodegenerative Diseases | 5 |
| Brain Diseases | 4 |
| Central Nervous System Diseases | 4 |
| Alzheimer Disease | 3 |
| Dementia | 3 |
| Mental Disorders | 3 |
| Muscle Cramp | 2 |
| Neuromuscular Diseases | 2 |
| Spasm | 2 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.